288 related articles for article (PubMed ID: 15688845)
1. [Amphotericin B: the end of an era].
Rommes JH; Spronk PE; Saene HK
Ned Tijdschr Geneeskd; 2005 Jan; 149(2):106; author reply 106-7. PubMed ID: 15688845
[No Abstract] [Full Text] [Related]
2. [Amphotericin B: the end of an era].
van der Klooster JM; Zandstra DF
Ned Tijdschr Geneeskd; 2005 Jan; 149(2):107-8; author reply 108. PubMed ID: 15688846
[No Abstract] [Full Text] [Related]
3. [Amphotericin B: the end of an era].
Oude Lashof AM; Kullberg BJ
Ned Tijdschr Geneeskd; 2004 Aug; 148(34):1665-8. PubMed ID: 15453116
[TBL] [Abstract][Full Text] [Related]
4. [New aspects in treatment of systemic mycoses].
Presterl E; Graninger W
Wien Klin Wochenschr; 1998 Nov; 110(21):740-50. PubMed ID: 9871965
[TBL] [Abstract][Full Text] [Related]
5. Controlled trials of amphotericin B lipid complex and other lipid-associated formulations.
Winston DJ; Schiller GJ
Clin Infect Dis; 2000 Jan; 30(1):236-7. PubMed ID: 10619780
[No Abstract] [Full Text] [Related]
6. Drugs for treatment of fungal infections.
Med Lett Drugs Ther; 1990 Jun; 32(820):58-60. PubMed ID: 2348801
[No Abstract] [Full Text] [Related]
7. [Commonly used antifungal agents in the treatment of systemic mycoses].
Berenguer Berenguer J
Rev Clin Esp; 1995 Oct; 195 Suppl 3():58-65. PubMed ID: 9441308
[No Abstract] [Full Text] [Related]
8. Treatment of invasive fungal infections.
Warnock DW
Hosp Med; 1998 Apr; 59(4):266-7. PubMed ID: 9722362
[No Abstract] [Full Text] [Related]
9. Amphotericin B plus fluconazole for HIV-associated cryptococcal meningitis.
Harrison TS
Clin Infect Dis; 2009 Jun; 48(12):1784-6. PubMed ID: 19441979
[No Abstract] [Full Text] [Related]
10. A brief review of antifungal therapy for deep fungal infection.
Muller RJ
Oncology (Williston Park); 2001 Nov; 15(11 Suppl 9):21-5. PubMed ID: 11757847
[TBL] [Abstract][Full Text] [Related]
11. Systemic antifungal drugs.
Med Lett Drugs Ther; 1994 Feb; 36(916):16-8. PubMed ID: 8302208
[No Abstract] [Full Text] [Related]
12. Systemic antifungal drugs.
Med Lett Drugs Ther; 1996 Feb; 38(967):10-2. PubMed ID: 8559113
[No Abstract] [Full Text] [Related]
13. Fluconazole-resistant pseudomembranous oral candidiasis.
Shetty K
Ann Pharmacother; 2006 May; 40(5):993. PubMed ID: 16638917
[No Abstract] [Full Text] [Related]
14. Clinical roundtable monograph: safety and efficacy of lipid-based amphotericin B.
Bellmann R; Cleary JD; Sterba J
Clin Adv Hematol Oncol; 2009 Apr; 7(4):1-8. PubMed ID: 19537331
[TBL] [Abstract][Full Text] [Related]
15. [Advances in the treatment of severe refractory infections. 4) Deep fungal infection].
Watanabe K
Nihon Naika Gakkai Zasshi; 1998 Nov; 87(11):2257-62. PubMed ID: 9921211
[No Abstract] [Full Text] [Related]
16. Mortality rates in comparative trials of formulations of amphotericin B.
Frothingham R
Clin Infect Dis; 2001 Aug; 33(4):582-3. PubMed ID: 11462201
[No Abstract] [Full Text] [Related]
17. Fungal infections in neonates: update on prevention and treatment.
Kaufman DA
Minerva Ginecol; 2007 Jun; 59(3):311-29. PubMed ID: 17576407
[TBL] [Abstract][Full Text] [Related]
18. Management of systemic fungal infections: alternatives to itraconazole.
Herbrecht R; Nivoix Y; Fohrer C; Natarajan-Amé S; Letscher-Bru V
J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i39-i48. PubMed ID: 16120633
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal voriconazole for drug-resistant fungal endophthalmitis: case series.
Sen P; Gopal L; Sen PR
Retina; 2006 Oct; 26(8):935-9. PubMed ID: 17031296
[TBL] [Abstract][Full Text] [Related]
20. Liposomal amphotericin B for fever and neutropenia.
Wingard JR
N Engl J Med; 1999 Oct; 341(15):1153; author reply 1154-5. PubMed ID: 10515753
[No Abstract] [Full Text] [Related]
[Next] [New Search]
